ENTG Stock Analysis: Entegris | NASDAQ
Semiconductor Equipment & Materials | NASDAQ, USA | Market Cap: 24.586m USD | 12M Return: 101.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 551M
EPS Trend: 29.8%
Qual. Beats: 2
Rev. Trend: -84.2%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Entegris, Inc. (NASDAQ: ENTG) is a U.S.-based supplier of advanced materials and process solutions serving primarily the semiconductor manufacturing value chain, with additional exposure to adjacent high-technology end markets. The company operates two reporting segments: Materials Solutions (MS), which provides deposition materials, chemical mechanical planarization (CMP) slurries and pads, ion implantation gases, and formulated etch and clean chemistries; and Advanced Purity Solutions (APS), which delivers filtration, purification, and contamination-control products used in semiconductor and other high-tech production environments.
The companys customer base spans the semiconductor ecosystem - including logic and memory device manufacturers, wafer growers, equipment OEMs, gas and chemical suppliers, and outsourced semiconductor assembly and test (OSAT) facilities - alongside manufacturers in flat panel display, hard disk drives, solar, life sciences, aerospace, and biomedical devices. As a specialty materials supplier, Entegris typically sits upstream of chipmakers in the supply chain, where products must undergo lengthy qualification cycles with fabs, creating high switching costs and customer stickiness characteristic of the semiconductor materials sub-industry.
Founded in 1966 and headquartered in Billerica, Massachusetts, Entegris generated revenue across key regions including North America, Taiwan, South Korea, Japan, China, Europe, and Southeast Asia, reflecting the global footprint of semiconductor manufacturing.
- AI semiconductor capex boom lifts materials and filtration demand
- Memory chip cycle recovery drives Materials Solutions segment growth
- China export curbs pose risk to significant regional revenue
| Net Income: 264.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 4.84 > 1.0 |
| NWC/Revenue: 38.03% < 20% (prev 35.69%; Δ 2.34% < -1%) |
| CFO/TA 0.09 > 3% & CFO 738.0m > Net Income 264.5m |
| Net Debt (3.42b) to EBITDA (845.8m): 4.04 < 3 |
| Current Ratio: 3.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (153.2m) vs 12m ago 0.79% < -2% |
| Gross Margin: 43.22% > 18% (prev 44.56%; Δ -1.34% > 0.5%) |
| Asset Turnover: 38.27% > 50% (prev 38.47%; Δ -0.20% > 0%) |
| Interest Coverage Ratio: 2.44 > 6 (EBIT TTM 472.1m / Interest Expense TTM 193.4m) |
| A: 0.15 (Total Current Assets 1.79b - Total Current Liabilities 555.6m) / Total Assets 8.48b |
| B: 0.19 (Retained Earnings 1.64b / Total Assets 8.48b) |
| C: 0.06 (EBIT TTM 472.1m / Avg Total Assets 8.45b) |
| D: 0.91 (Book Value of Equity 4.05b / Total Liabilities 4.43b) |
| Altman-Z'' = 2.92 = A |
| DSRI: 0.99 (Receivables 529.5m/538.5m, Revenue 3.24b/3.24b) |
| GMI: 1.03 (GM 44.56% / 43.22%) |
| AQI: 0.98 (AQ_t 0.58 / AQ_t-1 0.60) |
| SGI: 1.00 (Revenue 3.24b / 3.24b) |
| TATA: -0.06 (NI 264.5m - CFO 738.0m) / TA 8.48b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of July 02, 2026, the stock is trading at USD 165.19 with a total of 4,617,868 shares traded. Over the past week, the price has changed by -3.66%, over one month by +21.70%, over three months by +39.25% and over the past year by +101.36%.
Current recommended Stop Loss: 143.00 (which is 13.4% or 1.7 ATR below the current price).
Entegris has received a consensus analysts rating of 4.44. Therefore, it is recommended to buy ENTG.
- StrongBuy: 5
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 160.6 | -2.8% |
P/E Trailing = 93.3121
P/E Forward = 46.5116
P/S = 7.5992
P/B = 6.0718
P/EG = 1.9768
Revenue TTM = 3.24b USD
EBIT TTM = 472.1m USD
EBITDA TTM = 845.8m USD
Long Term Debt = 3.65b USD (from longTermDebt, last quarter)
Short Term Debt = 15.8m USD (from shortTermDebt, last fiscal year)
Debt = 3.86b USD (from shortLongTermDebtTotal, last quarter) + Leases 106.3m
Net Debt = 3.42b USD (calculated: Debt 3.86b - CCE 442.7m)
Enterprise Value = 28.0b USD (24.6b + Debt 3.86b - CCE 442.7m)
Interest Coverage Ratio = 2.44 (Ebit TTM 472.1m / Interest Expense TTM 193.4m)
EV/FCF = 41.20x (Enterprise Value 28.0b / FCF TTM 679.8m)
FCF Yield = 2.43% (FCF TTM 679.8m / Enterprise Value 28.0b)
FCF Margin = 21.01% (FCF TTM 679.8m / Revenue TTM 3.24b)
Net Margin = 8.18% (Net Income TTM 264.5m / Revenue TTM 3.24b)
Gross Margin = 43.22% ((Revenue TTM 3.24b - Cost of Revenue TTM 1.84b) / Revenue TTM)
Gross Margin QoQ = 41.24% (prev 43.77%)
Tobins Q-Ratio = 3.30 (Enterprise Value 28.0b / Total Assets 8.48b)
Interest Expense / Debt = 5.01% (Interest Expense 193.4m / Debt 3.86b)
Taxrate = 3.92% (10.8m / 275.8m)
NOPAT = 453.6m (EBIT 472.1m * (1 - 3.92%))
Current Ratio = 3.21 (Total Current Assets 1.79b / Total Current Liabilities 555.6m)
Debt / Equity = 0.95 (Debt 3.86b / totalStockholderEquity, last quarter 4.05b)
Debt / EBITDA = 4.04 (Net Debt 3.42b / EBITDA 845.8m)
Debt / FCF = 5.03 (Net Debt 3.42b / FCF TTM 679.8m)
Total Stockholder Equity = 3.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.13% (Net Income 264.5m / Total Assets 8.48b)
RoE = 6.74% (Net Income TTM 264.5m / Total Stockholder Equity 3.93b)
RoCE = 6.23% (EBIT 472.1m / Capital Employed (Equity 3.93b + L.T.Debt 3.65b))
RoIC = 5.84% (NOPAT 453.6m / Invested Capital 7.77b)
WACC = 12.88% (E(24.6b)/V(28.4b) * Re(14.15%) + D(3.86b)/V(28.4b) * Rd(5.01%) * (1-Tc(0.04)))
Discount Rate = 14.15% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 94.39 | Cagr: 0.55%
[DCF] Terminal Value 64.75% ; FCFF base≈515.1m ; Y1≈590.4m ; Y5≈869.0m
[DCF] Fair Price = 25.00 (EV 7.23b - Net Debt 3.42b = Equity 3.81b / Shares 152.3m; r=12.88% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 29.85 | EPS CAGR: 3.24% | SUE: 4.0 | # QB: 2
Revenue Correlation: -84.23 | Revenue CAGR: -5.11% | SUE: 0.33 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.92 | Chg30d=+2.02% | Revisions=+17% | Analysts=10
EPS current Year (2026-12-31): EPS=3.64 | Chg30d=+0.12% | Revisions=+71% | GrowthEPS=+32.3% | GrowthRev=+7.8%
EPS next Year (2027-12-31): EPS=4.62 | Chg30d=+0.20% | Revisions=+47% | GrowthEPS=+27.0% | GrowthRev=+11.5%
[Analyst] Revisions Ratio: +71%